Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
July 14 2014 - 3:32PM
Edgar (US Regulatory)
|
|
|
OMB APPROVAL
|
OMB Number:
|
|
3235-0167
|
Expires:
|
|
December 31, 2014
|
Estimated average burden
hours per response
|
|
1.50
|
|
UNITED STATES
|
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO
FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number
001-34641
FURIEX PHARMACEUTICALS, INC.
(Exact name of registrant as specified
in its charter)
3900 Paramount Parkway, Suite 150
Morrisville, North Carolina 27560
Telephone: (919) 456-7800
(Address, including zip code, and
telephone number, including area code, of registrants principal executive offices)
Common Stock, $0.001 par value
(Title of each class of securities
covered by this Form)
None
(Titles of all other classes of
securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the
appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
|
|
Rule 12g-4(a)(1)
|
|
x
|
|
|
Rule 12g-4(a)(2)
|
|
¨
|
|
|
Rule 12h-3(b)(1)(i)
|
|
x
|
|
|
Rule 12h-3(b)(1)(ii)
|
|
¨
|
|
|
Rule 15d-6
|
|
¨
|
|
|
|
|
|
Approximate number of holders of record as to the certification or notice date:
|
|
one (1)
|
Pursuant to the requirements of the Securities Exchange Act of 1934 Furiex Pharmaceuticals, Inc. has
caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
Date:
|
|
July 14, 2014
|
|
|
|
By:
|
|
/s/ A. Robert D. Bailey
|
|
|
|
|
|
|
|
|
Name: A. Robert D. Bailey
|
|
|
|
|
|
|
|
|
Title: President
|
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities
Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and
title of the person signing the form shall be typed or printed under the signature.
|
|
|
SEC 2069 (01-02)
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
(MM) (NASDAQ:FURX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:FURX)
Historical Stock Chart
From Jul 2023 to Jul 2024